Cargando…

Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis

This retrospective study aimed to evaluate radiation-induced pneumonitis (RIP) and a related condition that we define in this report—prolonged minimal RIP (pmRIP)—after stereotactic body radiotherapy (SBRT) for Stage I primary lung cancer in patients with chronic obstructive pulmonary disease (COPD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Toshihiko, Shiomi, Hiroya, Oh, Ryoong-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497392/ https://www.ncbi.nlm.nih.gov/pubmed/25887042 http://dx.doi.org/10.1093/jrr/rrv019

Ejemplares similares

Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer
por: Miura, Hideharu, et al.
Publicado: (2015)

Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy
por: Miura, Hideharu, et al.
Publicado: (2014)

Adaptive replanning intensity-modulated radiotherapy for choroidal metastasis of breast cancer using optical coherence tomography
por: INOUE, Toshihiko, et al.
Publicado: (2014)

Feasibility study of a non-invasive eye fixation and monitoring device using a right-angle prism mirror for intensity-modulated radiotherapy for choroidal melanoma
por: Inoue, Toshihiko, et al.
Publicado: (2017)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023)

Threshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging
por: Doi, Hiroshi, et al.
Publicado: (2016)

Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
por: Harris, Alexander A, et al.
Publicado: (2020)

Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2020)

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy
por: Chapman, Christopher H., et al.
Publicado: (2018)

Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2021)

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Radiation-induced organizing pneumonia after stereotactic body radiotherapy for lung tumor
por: Ochiai, Satoru, et al.
Publicado: (2015)

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife
por: Fukuda, Shoichi, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

3D deep convolution neural network for radiation pneumonitis prediction following stereotactic body radiotherapy
por: Kapoor, Rishabh, et al.
Publicado: (2022)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
por: Jiao, Yuxin, et al.
Publicado: (2020)

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer
por: Kita, Nozomi, et al.
Publicado: (2023)

Development of raster scanning IMRT using a robotic radiosurgery system
por: Shiomi, Hiroya, et al.
Publicado: (2021)

Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion
por: Miura, Hideharu, et al.
Publicado: (2013)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results
por: Bijlani, Akash, et al.
Publicado: (2013)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer
por: Nakamura, Masaki, et al.
Publicado: (2016)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
por: Pepin, Abigail N., et al.
Publicado: (2022)

Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy
por: Dibs, Khaled, et al.
Publicado: (2022)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
por: Hara, Yu, et al.
Publicado: (2016)

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma
por: Sun, Lu, et al.
Publicado: (2023)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy
por: Ye, Luxi, et al.
Publicado: (2019)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Spine Stereotactic Body Radiotherapy to Three or More Contiguous Vertebral Levels
por: Dibs, Khaled, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gg452vdnt8lrilrbpkf1cuosq2